Pharma Mirror

FEBRUARY 18, 2022

By Christopher Weikart, Chief Scientist, SiO2 Materials Science Even though drugs are meant to save lives, the primary packaging used for delivering drug therapies and vaccines may actually be putting us in danger. The post 7 Problems with Using Borosilicate Glass to Package Drugs appeared first on Pharma Mirror Magazine.

Packaging 52

Packaging Vaccines 52

PharmaTech

OCTOBER 27, 2024

Compendial testing covers a wide array of materials, subjects, and locations designed to create standards and programs that ensure the quality and safety of approved articles for a geographical location or areas such as USP (For the United States market) or Ph Eur (For European markets).

Packaging 52

Packaging 52

Pharma Mirror

DECEMBER 12, 2021

The glass used to package, store, and deliver drugs today was created in 1881 — just 16 years after the Civil War ended — and has changed very little since then, and it’s these vials that drug companies, who are creating ever-evolving, more complex drugs, are beholden to use.

Packaging 52

Packaging 52

European Pharmaceutical Review

OCTOBER 3, 2024

Preparing for the impact of EU GMP Annex 1 on primary packaging Niamh Bissett and Dr Ana Kuschel West Pharmaceutical Services, Inc. Login or create an account to download your copy of our Issue now!

Packaging 59

Packaging Vaccines 59

European Pharmaceutical Review

FEBRUARY 2, 2023

The winners of Pharmapack Europe’s 2023 awards have been announced, presented across a range of innovative recyclable packaging, drug delivery solutions, and reusable connected devices. The winner in the Eco-Design category was a high grade, 100 percent PET blister packaging.

Packaging 98

Packaging Medication Delivery Biosimilars 98

STAT

AUGUST 23, 2024

The comments came in response to an article  The Financial Times  that claimed the company is considered changing the location of a $578 million vaccine manufacturing plant from Liverpool to Philadelphia because the new U.K. Labor government is angling to reduce a subsidy program.

Vaccines 203

Vaccines Packaging 203

GMPSOP

AUGUST 11, 2024

This article explores the essential components of the clinical supply chain for investigational pharmaceutical products and medical devices and provides a comprehensive guide to maintaining the highest standards in clinical trials. Investigational materials are typically not manufactured or packaged in registered product-dedicated facilities.

Packaging 52

Packaging Documentation Labelling Dosage 52

Express Pharma

DECEMBER 11, 2023

In this article, we delve into the highlights of the Chandigarh Pharma Summit 2023, and showcase the key takeaways and insights from the presentations and discussions at the event. Embracing innovation in pharma packaging is vital become future Shivaji Chakraborty, Asst.

Packaging 100

Packaging Communication Documentation 100

Express Pharma

DECEMBER 11, 2023

So, in this article, we delve into this dynamic market to explore the driving factors behind its exponential growth and the trends shaping the market landscape while evaluating the pain points that need to be addressed for sustained growth. per cent from 2016 to 2022 for the pharma cold chain packaging segment in India.

Packaging 114

Packaging Vaccines 114

Pharma Packaging Solutions

JUNE 29, 2020

Someone posing as us (under the names Carton Service or Pharma Packaging Solutions) is contacting potential job seekers and making an offer of employment. Pharma Packaging Solutions DOES NOT have remote work job opportunities. Carton Service and Pharma Packaging Solutions DO NOT text job offers. Carton Service Inc./Pharma

Packaging 52

Packaging 52

Big Molecule Watch

FEBRUARY 20, 2024

DMFs are submissions to the FDA “used to provide confidential, detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of human drug products.” On February 12, the FDA issued a final rule regarding the use of Drug Master Files (“DMF”) in Biologics License Applications.

Packaging 57

Packaging 57

ID Stewardship

OCTOBER 14, 2024

In this article an infectious diseases pharmacist discusses 5 examples where challenging antibiotic workflows can be an issue. BCPS, BCIDP Article Posted October 2024, First Released in the October 2024 IDstewardship Newsletter 1. The process is detailed in the package insert here. Authored By: Timothy P. Gauthier, Pharm.D.,

Compounding 52

Compounding Labelling Packaging Hospitals 52

Pharmacy Joe

OCTOBER 25, 2023

The removal appears to be in response to the publication of a 2021 article in the International Journal of Pharmaceutical Compounding. .” How is this possible when we all have referred to this list as the “ISMP’s Do Not Crush List” for over a decade?

Dosage 111

Dosage Inpatient Packaging Documentation 111

GMPSOP

MARCH 3, 2024

Cross contamination is dangerous in pharmaceutical industry as it can severely compromise patient safety if the content is not pure and the product package differs from what is written on the label. Premises for the product packaging areas must be specifically designed and laid out to reduce cross contamination risks.

Health and Personal Care Stores 52

Health and Personal Care Stores Packaging Labelling Documentation 52

European Pharmaceutical Review

MAY 2, 2023

Innovation in clinical trials (article): Why R&D innovation holds the key to greater patient impact … The post FDA releases draft guidance for decentralised clinical trials appeared first on European Pharmaceutical Review. This draft guidance builds on recommendations published by the agency in 2020.

Packaging 98

Packaging 98

European Pharmaceutical Review

JANUARY 25, 2024

In a survey conducted by The European Consumer Organisation (BEUC) during June and July 2022, in Belgium, Italy, Portugal and Spain, 79 percent of consumers said paper leaflets should be available inside the package even if there is an alternative QR code on it. 11 This requirement directly contradicts what is included in Article 63.

Packaging 98

Packaging Documentation Communication Pharmaceutical Companies 98

European Pharmaceutical Review

AUGUST 23, 2022

On- or in-dose authentication means that a security measure or anticounterfeit feature is integrated with the dosage form itself, offering product verification and traceability embedded into each medicine, rather than on the secondary package” WHO estimates that >50 percent of the drugs for sale on the internet are fake.

Dosage 98

Dosage Packaging Online Pharmacies Pharmaceutical Companies 98

The Honest Apothecary

MAY 7, 2023

Here I share some of the latest news, articles, editorials, or blog posts that fall generally under the theme of Pharma or healthcare. All article shared will be free to read and not locked behind an annoying paywall. .” ” PATCH. LĒF FARMS SALAD GREENS RECALL So much for eating healthy! “lēf Farms of Loudon, N.H.

Hospitals 52

Hospitals Packaging 52

GMPSOP

SEPTEMBER 22, 2022

Acceptable Quality Limit is used to make an informed decision whether to accept or reject an incoming packaging components lot by assessing the lot size and types of defects found during a pre-determined level of inspection. GMP Production facilities employ three types of inspection level at the time of packaging material sampling.

Packaging 52

Packaging Documentation Labelling 52

Safe Biologics

NOVEMBER 12, 2023

6 would prevent the HHS Secretary from requiring a switching study as part of the data package to receive the interchangeable designation. ASBM Letter to Congress Defends Interchangeability Standard In a letter to Senator Mike Lee (R-UT) dated September 27th, ASBM urged the Senator to reconsider his support for S.6 However, S.6

Biosimilars 130

Biosimilars Drug Pricing Packaging Labelling 130

pharmaphorum

NOVEMBER 11, 2022

Instead, the evidence package must translate this into clear clinical outcomes. ACCESS THE FULL ARTICLE HERE. Many therapies will be first in class with novel modes of action. However, for payers, as well as regulators, healthcare professionals, and patients, a new mode of action is not a value driver.

Packaging 52

Packaging 52

Pharmaceutical Technology

MAY 26, 2023

PWC predicts deal volumes to resemble prior years with the effect of the US Inflation Reduction Act on pricing better understood and less uncertainty surrounding business conditions, according to an article entitled Pharmaceutical & Life Sciences: US Deals 2023 Outlook published on the company’s website.

Packaging 52

Packaging 52

pharmaphorum

JANUARY 18, 2022

Primary Packaging material designers. Secondary packagers. POST CONFERENCE WORKSHOP A: EU MDR 2017/745 Article 117 Requirements. Overview of the workshop: The workshop is aimed to provide an introduction to the key elements of the Medical Device Regulation that Companies affected by article 117 need to consider.

Packaging 52

Packaging Documentation Vaccines Drug Development 52

Pharmaceutical Technology

SEPTEMBER 26, 2022

These include the multiprotocol nRF52 and nRF53 series systems-on-chip (SoCs) and the cellular nRF91 Series IoT systems-in-package (SiPs). This article was originally published in Verdict.co.uk. Also, the nRF7002 can be utilized with non-Nordic host devices.

Packaging 52

Packaging 52

pharmaphorum

FEBRUARY 9, 2021

As pharma marketers, you are always searching for ways to provide accurate information about your product and package it in a myriad of different ways–all while facing many restrictions. Read the full article on health-union.com. . And with nearly 1.1 The post 5 Ways to Make Your Pharma Marketing More Personal appeared first on.

Packaging 52

Packaging 52

GMPSOP

NOVEMBER 19, 2023

The scope of this article applies to all regulated medicinal products manufactured at a GMP site that undergo annual product quality review. The content of this article does not supersede or replace any local or international regulatory requirements. Subscribe f.

Documentation 52

Documentation Packaging Method Validation Process Improvement 52

Flip the Pharmacy

AUGUST 30, 2022

The change packages are wonderful resources, but let us not kid ourselves, they can be equally overwhelming. However, realize that overtime as you and your champion are working to implement any new service or change suggested in the monthly change packages, it will not be sustainable without involving additional staff. Build TRUST.

Community Pharmacies 52

Community Pharmacies Packaging Communication 52

Pharma Mirror

FEBRUARY 6, 2024

It has transformed from a “nice-to-have” into a “must-have” part of the evidence package, helping to contextualize clinical research and improve treatment understanding. In addition to utilizing RWE in clinical research, there is a growing trend toward implementing RWE early in the product development lifecycle.

Packaging 40

Packaging 40

GMPSOP

NOVEMBER 15, 2024

Stability testing ensures that the manufactured products remain safe, pure, and effective throughout their shelf life if they are kept in specified packaging and under environmental conditions. They are necessary for the API testing method and will also have to be conducted for the formulated and packaged product.

Packaging 59

Packaging Dosage Documentation Labelling 59

Pharmacy Joe

OCTOBER 25, 2023

The removal appears to be in response to the publication of a 2021 article in the International Journal of Pharmaceutical Compounding. .” How is this possible when we all have referred to this list as the “ISMP’s Do Not Crush List” for over a decade?

Dosage 52

Dosage Inpatient Packaging Documentation 52

Safe Biologics

DECEMBER 6, 2023

REMINDER: FDA Draft Guidance Would Remove Interchangeability Statement from Interchangeable Biosimilars Comments Due November 17th On September 15th, the Food and Drug Administration (FDA) released draft guidance removing the interchangeability statement from the product label/package insert. Read the full BioSpace article here.

Biosimilars 130

Biosimilars Packaging Labelling Drug Development 130

RX Note

MARCH 23, 2023

Today, stability information can be obtained from manufacturer’s labelling information (such as in the package insert), the USP compounding monographs, or peer-reviewed articles and references , such as articles in American Journal of Health-System Pharmacy, the International Journal of Pharmaceutical Compounding.

Compounding 52

Compounding Sterile Compounds Packaging Labelling 52

Quality Matters

NOVEMBER 5, 2024

Food and Drug Administration (FDA) by API manufacturers to provide confidential, detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of human drug products. API DMFs are documents containing information on APIs that are submitted to the U.S.

Pharmaceutical Manufacturing 75

Pharmaceutical Manufacturing Packaging Documentation 75

Pharmaceutical Technology

OCTOBER 23, 2022

The present article is applicable to solid medical devices but not fabrics, drapes, contact lenses or some other particular devices such as dialysis blood flow components. The main drawback of using EO as a sterilization agent is that it can leave toxic residues on the articles being processed. and 2.56mg respectively. Background.

Packaging 40

Packaging 40

pharmacy mentor

MARCH 12, 2023

In this article, we’ll explore the pharmacy industry landscape before and after the pharmacy digital revolution, with a focus on the impact of digital marketing on patient behaviour and experience. Enjoyed this article? Few things altered the course of Community Pharmacy’s destiny more than the digital revolution.

Community Pharmacies 97

Community Pharmacies Online Pharmacies Prescription Filling Packaging 97

Pharma Marketing Network

MARCH 25, 2023

This includes everything from the company’s website and social media presence to packaging and advertising. ” Entrepreneur, www.entrepreneur.com/article/314384. All communications, both internal and external, should reflect the brand’s values and personality. References: 1. ” Communiqué, communique.us/creating-strong-brand-identity-pharmaceutical-industry/.

Packaging 52

Packaging Communication 52

FDA Law Blog: Biosimilars

JANUARY 3, 2024

Specifically, CVM ensures that animal drugs are safe and effective, properly made, and adequately labeled and packaged; food-producing animals only take drugs that would be safe for humans to consume; pet foods and additives are safe; and educates the public, monitors the market, and encourages development of new animal health products.

Packaging 57

Packaging Labelling Vaccines 57